Showing 1 posts of 1 posts found.
Biotech firm CAP-CMV which is a spin-out of CEVEC Pharmaceuticals has appointed industry veteran Dr Albrecht Läufer as its chief …
UKRI backs five hubs developing AI tools for earlier disease detection
NEC joins €6.5m European project using AI for pandemic vaccine design
The evidence bar impacting UK medical cannabis access
Survey highlights mental health burden among rare disease patients and families
Addressing the rheumatic disease diagnostic gap in primary care